Median Technologies SA (ALMDT.PA) Stock
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Median Technologies SA
Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iCRO, an imaging service for oncology clinical trials; and eyonis, an end-to-end CADe/CADx software as medical devices. The company was founded in 2002 and is based in Valbonne, France.
Median Technologies SA is led by CEO Fredrik Brag, employs 199 people, headquartered in Valbonne, FR, publicly traded since 2011.
Median Technologies SA (ALMDT.PA) stock trades at $4.69 with a market capitalization of $229.86M. The stock is valued at a price-to-earnings (P/E) ratio of -12.45, price-to-sales of 9.79. Over the past 52 weeks the stock has ranged between $2.26 and $7.27, and currently trades 35.5% below its 52-week high.
On profitability, Median Technologies SA generates an operating margin of -57.75%, a net profit margin of -145.17%.
Official website: mediantechnologies.com